| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net income (loss) | ||||||
1,165,574 | -21,817 | -1,483 | ||||
Items not affecting cash: | ||||||
Inventory write-down | ||||||
29,440 | 0 | 0 | ||||
Share-based payments | ||||||
11,619 | 8,151 | 1,931 | ||||
Depreciation and amortization | ||||||
3,913 | 1,937 | 768 | ||||
Share of net loss from investments in equity accounted investees | ||||||
-2,009 | -723 | 127 | ||||
Gain on revaluation of derivative liabilities (Note 11) | ||||||
1,276,819 | 0 | 0 | ||||
Non-cash repurposing costs | ||||||
4,439 | 0 | 0 | ||||
Gain on disposal of other investments | ||||||
15,530 | 0 | 0 | ||||
Gain (Loss) On Revaluation Of Financial Liabilities | ||||||
197 | 0 | 0 | ||||
Equity Securities, FV-NI, Realized Gain (Loss) | ||||||
747 | 164 | - | ||||
Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments | ||||||
- | - | 3,746 | ||||
Income Tax Expense (Benefit) | ||||||
0 | 0 | -862 | ||||
Foreign exchange gain | ||||||
-115 | 9 | 0 | ||||
Non-cash sales and marketing | ||||||
410 | 0 | 0 | ||||
Non-cash interest | ||||||
25 | 0 | 0 | ||||
Net changes in non-cash working capital | ||||||
54,208 | -3,662 | 759 | ||||
Cash flows used in operating activities | ||||||
-130,007 | -7,517 | -4,278 | ||||
Investing activities | ||||||
Purchase of short-term investments | ||||||
299,923 | 0 | 0 | ||||
Repayment of purchase price liability | ||||||
0 | 0 | 1,997 | ||||
Investments in equity accounted investees | ||||||
1,658 | 480 | 830 | ||||
Investment in Vivo Cannabis (Vivo) | ||||||
0 | 0 | - | ||||
Investment in Vivo Cannabis (Vivo) | ||||||
- | - | 783 | ||||
Proceeds from sale of other investments | ||||||
19,614 | 747 | - | ||||
Proceeds from sale of other investments | ||||||
- | - | 8,388 | ||||
Payments To Exercise Warrants | ||||||
0 | 88 | 1,749 | ||||
Advances to joint ventures | ||||||
15,135 | 5,358 | 0 | ||||
Purchase of property, plant and equipment | ||||||
38,664 | 88,308 | 32,926 | ||||
Payment of accrued interest on construction loan payable | ||||||
89 | 143 | 0 | ||||
Purchase of intangible assets | ||||||
289 | 278 | 0 | ||||
Acquisition of Redwood | ||||||
224,295 | 0 | 0 | ||||
Advances on loans receivable | ||||||
43,337 | 0 | 0 | ||||
Proceeds from repayment of loans receivable | ||||||
237 | 0 | 0 | ||||
Cash flows provided (used) in investing activities | ||||||
-603,539 | -93,908 | -29,897 | ||||
Financing activities | ||||||
Increase in bank indebtedness | ||||||
0 | 11,583 | 5,022 | ||||
Repayment of lease obligations | ||||||
919 | 0 | 0 | ||||
Proceeds from exercise of Top-up Rights | ||||||
67,051 | 0 | 0 | ||||
Proceeds from exercise of warrants and options | ||||||
1,455 | 2,612 | 1,697 | ||||
Withholding taxes paid on share appreciation rights | ||||||
915 | 16 | 0 | ||||
Share issuance costs | ||||||
3,722 | 7,577 | 2,114 | ||||
Repayment of construction loan payable | ||||||
15,971 | 0 | 0 | ||||
Advance under Credit Facility | ||||||
48,715 | 0 | 0 | ||||
Repayment of Credit Facility | ||||||
48,309 | 0 | 0 | ||||
Repayment of mortgage payable | ||||||
0 | 0 | 3,084 | ||||
Transaction costs paid on construction loan payable | ||||||
0 | 0 | 989 | ||||
Cash flows provided (used) by financing activities | ||||||
1,856,941 | 122,112 | 39,074 | ||||
Effect of foreign currency translation on cash and cash equivalents | ||||||
52,371 | -4,085 | -152 | ||||
Increase (decrease) in cash and cash equivalents | ||||||
1,175,766 | 16,602 | 4,747 | ||||
Altria Investment | ||||||
Repayment of construction loan payable | ||||||
1,809,556 | 0 | 0 | ||||
Bought Deal Offerings | ||||||
Repayment of construction loan payable | ||||||
0 | 115,510 | 38,542 | ||||